Biogen (BIIB) Other Non Operating Income (2009 - 2015)

Biogen (BIIB) posted quarterly Other Non Operating Income of -$15.0 million for Q1 2015, down 167.56% year-over-year from $22.2 million in Q1 2014, and down 70.88% on a QoQ basis from -$8.8 million in Q4 2014.

Biogen (BIIB) Other Non Operating Income (2009 - 2015) Analysis & Trends

Biogen (BIIB) has reported Other Non Operating Income for 7 consecutive years, with -$15.0 million the latest figure, recorded in Q1 2015.

  • In Q1 2015, Other Non Operating Income fell 167.56% year-over-year to -$15.0 million; the TTM figure through Mar 2015 stood at -$35.2 million (down 35.1% YoY), while the FY2016 annual figure was -$217.4 million, down 75.75% from the prior year.
  • Other Non Operating Income came in at -$15.0 million for Q1 2015 at Biogen, down from -$8.8 million in the prior quarter.
  • The five-year high for Other Non Operating Income was $15.1 million in Q1 2012, with the low at -$16.3 million in Q3 2014.
  • Average Other Non Operating Income over 5 years is -$5.9 million, with a median of -$5.6 million recorded in 2014.
  • Across the five-year window, Other Non Operating Income sank 453.49% in 2013 and soared 146.61% in 2014, its largest moves.
  • Year by year, Other Non Operating Income stood at -$4.0 million in 2011, then slumped by 259.68% to -$14.3 million in 2012, then jumped by 62.39% to -$5.4 million in 2013, then slumped by 63.16% to -$8.8 million in 2014, then plunged by 70.88% to -$15.0 million in 2015.
  • According to Business Quant data, Other Non Operating Income over the past three periods registered -$15.0 million, -$8.8 million, and -$16.3 million for Q1 2015, Q4 2014, and Q3 2014 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,066.16 Bn 1,060.88 Bn 16.22 Bn
2 Johnson & Johnson 611.69 Bn 589.64 Bn 15.96 Bn
3 AbbVie 444.34 Bn 434.99 Bn 10.78 Bn
4 Astrazeneca 284.94 Bn 277.05 Bn 12.61 Bn
5 Merck 224.23 Bn 218.58 Bn 12.09 Bn
6 Amgen 195.12 Bn 183.08 Bn 5.87 Bn
7 Gilead Sciences 156.45 Bn 148.73 Bn 5.52 Bn
8 Pfizer 136.01 Bn 123.24 Bn -1.21 Bn
9 Novartis Ag 113.45 Bn 113.67 Bn -
10 Biogen 30.87 Bn 26.59 Bn 1.82 Bn

Historic Data

Download Data
DateValue
Mar 31, 2015 -14.99 Mn
Dec 31, 2014 -8.77 Mn
Sep 30, 2014 -16.29 Mn
Jun 30, 2014 4.86 Mn
Mar 31, 2014 -5.60 Mn
Dec 31, 2013 -5.38 Mn
Sep 30, 2013 -4.64 Mn
Jun 30, 2013 -10.43 Mn
Mar 31, 2013 -14.46 Mn
Dec 31, 2012 -14.29 Mn
Sep 30, 2012 -4.55 Mn
Jun 30, 2012 2.95 Mn
Mar 31, 2012 15.14 Mn
Dec 31, 2011 -3.97 Mn
Sep 30, 2011 -7.73 Mn
Dec 31, 2010 -4.70 Mn
Sep 30, 2010 -6.90 Mn
Jun 30, 2010 1.00 Mn
Mar 31, 2010 -8.40 Mn
Dec 31, 2009 6.40 Mn